iZafe Group AB (publ) (STO:IZAFE.B)
0.2580
+0.0010 (0.39%)
Jun 23, 2025, 5:11 PM CET
iZafe Group AB Revenue
iZafe Group AB had revenue of 1.32M SEK in the quarter ending March 31, 2025, a decrease of -61.35%. This brings the company's revenue in the last twelve months to 5.86M, up 17.15% year-over-year. In the year 2024, iZafe Group AB had annual revenue of 7.95M with 336.55% growth.
Revenue (ttm)
5.86M
Revenue Growth
+17.15%
P/S Ratio
14.16
Revenue / Employee
837.43K
Employees
7
Market Cap
83.01M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.95M | 6.13M | 336.55% |
Dec 31, 2023 | 1.82M | 1.09M | 149.93% |
Dec 31, 2022 | 729.00K | 287.00K | 64.93% |
Dec 31, 2021 | 442.00K | -9.05M | -95.35% |
Dec 31, 2020 | 9.50M | -4.83M | -33.72% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.24B |
Sectra AB | 3.31B |
Getinge AB | 35.57B |
Asker Healthcare Group AB | 15.57B |
Medicover AB | 23.56B |
Camurus AB | 2.04B |
AddLife AB | 10.42B |
Vimian Group AB | 4.24B |